| Specialty Retail Industry | Consumer Discretionary Sector | Itsuro Yoshida CEO | JPX Exchange | JP3623150004 ISIN |
| JP Country | 4,588 Employees | 29 Sep 2026 Last Dividend | 27 Mar 2019 Last Split | - IPO Date |
Towa Pharmaceutical Co., Ltd. is a comprehensive pharmaceutical company based in Osaka, Japan, with a long history dating back to 1951. Engaged primarily in the research, development, production, and sale of ethical drugs, active pharmaceutical ingredients, and intermediates, Towa Pharmaceutical Co., Ltd. stands out in the Japanese pharmaceutical industry. With a focus on serving the healthcare sector, the company leverages its expertise to contribute to therapeutic areas, including the digestive and nervous systems, and allergic diseases, among others. Moreover, its commitment to innovation extends beyond pharmaceuticals, as it also encompasses IT services related to healthcare and disease risk testing services, highlighting its multifaceted approach to improving patient care and health outcomes.
Specializing in the development and distribution of ethical drugs, Towa Pharmaceutical Co., Ltd. focuses on medications that require a physician's prescription. Their products cover various therapeutic areas such as digestive system disorders, nervous system ailments, and allergic diseases, demonstrating the company's commitment to addressing a wide range of medical needs within the healthcare landscape.
A key player in the pharmaceutical industry, the company manufactures and provides high-quality active pharmaceutical ingredients and intermediates. This supports not only its own drug development endeavors but also the wider pharmaceutical industry, facilitating the creation of a range of medications and treatments.
Towa Pharmaceutical Co., Ltd. offers an array of vitamins and antibiotic treatments, catering to the essential health needs of diverse patient demographics. Furthermore, the company is actively involved in the oncology sector, providing critical cancer treatment solutions that contribute significantly to patient care in this challenging therapeutic area.
Recognizing the increasingly vital role of information technology in healthcare, Towa Pharmaceutical extends its offerings to include IT services specifically tailored to the healthcare sector. This entails developing and implementing systems that enhance the efficiency of healthcare delivery and patient care management.
Amid growing awareness of preventative healthcare, the company offers disease risk testing services. These services aim to identify the potential risk of diseases early on, thereby enabling individuals to take proactive steps towards preventing the onset of illness through timely interventions.
Investing in the research and development of diagnostic drugs signifies Towa Pharmaceutical Co., Ltd.'s dedication to advancing medical science. By focusing on diagnostics, the company underlines the importance of accurate, early detection in the effective treatment of diseases, improving patient outcomes.
In addition to its pharmaceutical products, the company engages in the planning, development, and OEM (Original Equipment Manufacturer) manufacturing of health food, general food items, and other related products. This diversification illustrates the company's versatile approach to health and wellness, extending its impact beyond traditional pharmaceuticals.